Cargando…

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes

Detalles Bibliográficos
Autores principales: Gros, Alena, Tran, Eric, Parkhurst, Maria R, Anna, Pasetto, Ilyas, Sadia, Prickett, Todd D, Gartner, Jared J, Robbins, Paul F, Crystal, Jessica S, Trebska-Mcgowan, Kasia, Wudnerlich, John R, Yang, James C, Rosenberg, Steven A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645288/
http://dx.doi.org/10.1186/2051-1426-3-S2-O2
_version_ 1782400799991660544
author Gros, Alena
Tran, Eric
Parkhurst, Maria R
Anna, Pasetto
Ilyas, Sadia
Prickett, Todd D
Gartner, Jared J
Robbins, Paul F
Crystal, Jessica S
Trebska-Mcgowan, Kasia
Wudnerlich, John R
Yang, James C
Rosenberg, Steven A
author_facet Gros, Alena
Tran, Eric
Parkhurst, Maria R
Anna, Pasetto
Ilyas, Sadia
Prickett, Todd D
Gartner, Jared J
Robbins, Paul F
Crystal, Jessica S
Trebska-Mcgowan, Kasia
Wudnerlich, John R
Yang, James C
Rosenberg, Steven A
author_sort Gros, Alena
collection PubMed
description
format Online
Article
Text
id pubmed-4645288
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46452882015-11-20 Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes Gros, Alena Tran, Eric Parkhurst, Maria R Anna, Pasetto Ilyas, Sadia Prickett, Todd D Gartner, Jared J Robbins, Paul F Crystal, Jessica S Trebska-Mcgowan, Kasia Wudnerlich, John R Yang, James C Rosenberg, Steven A J Immunother Cancer Oral Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645288/ http://dx.doi.org/10.1186/2051-1426-3-S2-O2 Text en Copyright © 2015 Gros et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Gros, Alena
Tran, Eric
Parkhurst, Maria R
Anna, Pasetto
Ilyas, Sadia
Prickett, Todd D
Gartner, Jared J
Robbins, Paul F
Crystal, Jessica S
Trebska-Mcgowan, Kasia
Wudnerlich, John R
Yang, James C
Rosenberg, Steven A
Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
title Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
title_full Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
title_fullStr Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
title_full_unstemmed Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
title_short Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
title_sort selection of circulating pd-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645288/
http://dx.doi.org/10.1186/2051-1426-3-S2-O2
work_keys_str_mv AT grosalena selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT traneric selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT parkhurstmariar selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT annapasetto selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT ilyassadia selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT pricketttoddd selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT gartnerjaredj selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT robbinspaulf selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT crystaljessicas selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT trebskamcgowankasia selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT wudnerlichjohnr selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT yangjamesc selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes
AT rosenbergstevena selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes